6533b862fe1ef96bd12c7714
RESEARCH PRODUCT
Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour
Ricardo Alves MesquitaAline Cristina Batista Rodrigues JohannPatrícia Carlos CaldeiraRicardo Santiago GomezMaria Cássia Ferreira De AguiarMarcelo Vidigal Caliarisubject
Pathologymedicine.medical_specialtyStatistical differenceOdontologíaKeratocystic odontogenic tumourmedicineMetallothioneinHumansStatistical analysisInverse correlationGeneral DentistryOral Medicine and Pathologybusiness.industryResearchSyndromemedicine.disease:CIENCIAS MÉDICAS [UNESCO]ImmunohistochemistryCiencias de la saludKi-67 AntigenOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASOdontogenic CystsImmunohistochemistrySurgeryMetallothioneinbusinessNon syndromicdescription
Background To compare the metallothionein (MT) immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour (KOT), to correlate MT with cellular proliferation, and to evaluate the influence of inflammation in MT. Material and Methods Fourteen cases of KOT were submitted to immunohistochemistry for MT and Ki-67 analysis. The lesions were grouped according to their grade of inflammation, and statistical analysis was performed. Results MT was higher in non-syndromic KOT than in syndromic KOT (p<0.05). No statistical difference in Ki-67 could be identified; however, an inverse correlation was observed between MT and Ki-67 in both lesions. When analysing inflammation, non-syndromic KOT showed no differences in either MT or Ki-67. Conclusions The MT immunophenotype of syndromic KOT was different from non-syndromic KOT. MT might not be involved in the proliferation control of both KOT. MT and Ki-67 immunoexpressions proved to be unaffected by inflammation in non-syndromic KOT. Key words: Odontogenic tumours, basal cell nevus syndrome, metallothionein, Ki-67 Antigen, immunohistoche-mistry.
year | journal | country | edition | language |
---|---|---|---|---|
2015-03-16 |